What is the main purpose of this 8-K filing?

The primary purpose of this 8-K is to provide investors with updated financial information that reflects the completed separation of GE's HealthCare business and its reclassification as discontinued operations. It also includes preliminary unaudited supplemental financial information for 2022 to show GE's financial position and performance post-spin-off.

How does the GE HealthCare spin-off affect GE's financial reporting?

Following the spin-off, GE HealthCare is no longer consolidated into GE's financial results. Its historical financial results will be reported as discontinued operations beginning in the first quarter of 2023. GE will also account for its remaining ~19.9% ownership in GE HealthCare at fair value within its continuing operations.

Does this filing include revised financial statements for GE?

No, this Form 8-K explicitly states that it does not revise or restate previously filed Consolidated Statements of Financial Position, Statements of Earnings, or Statements of Cash Flows. The information provided is supplemental and preliminary, intended to illustrate the financial impact of the GE HealthCare separation.

What is the significance of GE no longer consolidating GE HealthCare?

For investors, this means that GE's future reported revenues, profits, assets, and liabilities will not include those of GE HealthCare. The financial performance of GE HealthCare will be presented separately as discontinued operations in historical periods and will no longer be part of GE's core ongoing business operations going forward. This allows investors to better assess the performance of GE's remaining businesses (such as Aviation and Power).

GE 8-K: Regulation FD — Feb 15, 2023

Summary

This Form 8-K filing from General Electric (GE) primarily provides updated financial information reflecting the recent spin-off of its GE HealthCare business. As of January 3, 2023, GE completed the distribution of approximately 80.1% of GE HealthCare's outstanding shares, making it an independent publicly traded company under the symbol "GEHC". Consequently, GE will no longer consolidate GE HealthCare's financial results and will begin reporting its historical results as discontinued operations from the first quarter of 2023 onwards. GE is furnishing preliminary unaudited supplemental financial information for the year ended December 31, 2022, and interim periods within 2022. This information includes a reclassification of the HealthCare business into discontinued operations. Investors should note that this filing does not revise previously filed financial statements but provides a clearer picture of GE's financial position and performance post-separation. GE will also prospectively measure its remaining 19.9% ownership interest in GE HealthCare at fair value in continuing operations.

Key Highlights

1Completed spin-off of GE HealthCare business (GEHC) on January 3, 2023, distributing ~80.1% of shares.
2GE HealthCare is now an independent public company trading on Nasdaq under symbol "GEHC".
3GE will no longer consolidate GE HealthCare's financial results.
4GE HealthCare's historical results will be reported as discontinued operations starting Q1 2023.
5GE will account for its remaining ~19.9% stake in GE HealthCare at fair value in continuing operations.
6Filing provides preliminary unaudited supplemental financial information for 2022 and interim periods, reflecting the reclassification.
7This 8-K does not revise previously filed financial statements but offers supplemental context.

GENERAL ELECTRIC CO 8-K Report, Regulation FD Disclosure (Feb 15, 2023)

Summary

Key Highlights

Frequently Asked Questions